A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective
© 2023. The Author(s)..
People living with diabetes have many medical devices available to assist with disease management. A critical aspect that must be considered is how systems for continuous glucose monitoring and insulin pumps communicate with each other and how the data generated by these devices can be downloaded, integrated, presented and used. Not only is interoperability associated with practical challenges, but also devices must adhere to all aspects of regulatory and legal frameworks. Key issues around interoperability in terms of data ownership, privacy and the limitations of interoperability include where the responsibility/liability for device and data interoperability lies and the need for standard data-sharing protocols to allow the seamless integration of data from different sources. There is a need for standardised protocols for the open and transparent handling of data and secure integration of data into electronic health records. Here, we discuss the current status of interoperability in medical devices and data used in diabetes therapy, as well as regulatory and legal issues surrounding both device and data interoperability, focusing on Europe (including the UK) and the USA. We also discuss a potential future landscape in which a clear and transparent framework for interoperability and data handling also fulfils the needs of people living with diabetes and healthcare professionals.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:67 |
|---|---|
| Enthalten in: |
Diabetologia - 67(2024), 2 vom: 02. Feb., Seite 236-245 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jendle, Johan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Big data |
|---|
| Anmerkungen: |
Date Completed 16.01.2024 Date Revised 12.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00125-023-06049-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365327255 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365327255 | ||
| 003 | DE-627 | ||
| 005 | 20240312233424.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00125-023-06049-5 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1324.xml |
| 035 | |a (DE-627)NLM365327255 | ||
| 035 | |a (NLM)38041737 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jendle, Johan |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.01.2024 | ||
| 500 | |a Date Revised 12.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a People living with diabetes have many medical devices available to assist with disease management. A critical aspect that must be considered is how systems for continuous glucose monitoring and insulin pumps communicate with each other and how the data generated by these devices can be downloaded, integrated, presented and used. Not only is interoperability associated with practical challenges, but also devices must adhere to all aspects of regulatory and legal frameworks. Key issues around interoperability in terms of data ownership, privacy and the limitations of interoperability include where the responsibility/liability for device and data interoperability lies and the need for standard data-sharing protocols to allow the seamless integration of data from different sources. There is a need for standardised protocols for the open and transparent handling of data and secure integration of data into electronic health records. Here, we discuss the current status of interoperability in medical devices and data used in diabetes therapy, as well as regulatory and legal issues surrounding both device and data interoperability, focusing on Europe (including the UK) and the USA. We also discuss a potential future landscape in which a clear and transparent framework for interoperability and data handling also fulfils the needs of people living with diabetes and healthcare professionals | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Big data | |
| 650 | 4 | |a Diabetes therapy | |
| 650 | 4 | |a Glucose monitoring | |
| 650 | 4 | |a Insulin delivery systems | |
| 650 | 4 | |a Interoperability | |
| 650 | 4 | |a Medical devices | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Blood Glucose |2 NLM | |
| 700 | 1 | |a Adolfsson, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Choudhary, Pratik |e verfasserin |4 aut | |
| 700 | 1 | |a Dovc, Klemen |e verfasserin |4 aut | |
| 700 | 1 | |a Fleming, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Klonoff, David C |e verfasserin |4 aut | |
| 700 | 1 | |a Mader, Julia K |e verfasserin |4 aut | |
| 700 | 1 | |a Oliver, Nick |e verfasserin |4 aut | |
| 700 | 1 | |a Sherr, Jennifer L |e verfasserin |4 aut | |
| 700 | 1 | |a Šoupal, Jan |e verfasserin |4 aut | |
| 700 | 1 | |a Heinemann, Lutz |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetologia |d 1966 |g 67(2024), 2 vom: 02. Feb., Seite 236-245 |w (DE-627)NLM000017035 |x 1432-0428 |7 nnns |
| 773 | 1 | 8 | |g volume:67 |g year:2024 |g number:2 |g day:02 |g month:02 |g pages:236-245 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00125-023-06049-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 67 |j 2024 |e 2 |b 02 |c 02 |h 236-245 | ||